eedq has been researched along with pirenzepine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creese, I; Norman, AB | 1 |
| Fain, JN; Sallés, J; Wallace, MA | 1 |
| Kameda, K; Koyama, T; Kusumi, I; Suzuki, K; Takahashi, Y | 1 |
3 other study(ies) available for eedq and pirenzepine
| Article | Year |
|---|---|
Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Topics: Animals; Benzodiazepinones; Binding, Competitive; Brain; Brain Stem; Cerebral Cortex; Hippocampus; Male; Pirenzepine; Quinolines; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine | 1986 |
Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
Topics: Alkylating Agents; Animals; Carbachol; Cerebral Cortex; Enzyme Activation; In Vitro Techniques; Male; Mustard Compounds; Piperidines; Pirenzepine; Propylbenzilylcholine Mustard; Quinolines; Quinuclidinyl Benzilate; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Type C Phospholipases | 1993 |
Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain Chemistry; Chlorpromazine; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Indoles; Isoindoles; Male; Olanzapine; Pirenzepine; Protein Binding; Quinolines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2000 |